Congo's Ebola outbreak poised to become deadliest on record

The head of the World Health Organization delivered a stark warning on Wednesday: the Ebola outbreak spreading through eastern Congo is moving so fast that it will soon eclipse the deadliest epidemic in recorded history. That benchmark—the West African outbreak of 2014 to 2016—killed more than 11,000 people and shook the world into action on vaccine development. The Congo outbreak has already claimed over 2,000 lives from more than 4,300 confirmed cases, and it is doing so at a pace no previous Ebola epidemic has matched.

What makes this outbreak particularly dangerous is the virus itself. The Bundibugyo strain responsible for the spread has no approved vaccines or treatments. Unlike the Zaire variant that dominated earlier outbreaks, this virus arrived without the medical arsenal that years of research had built. The outbreak was officially declared on May 15, but investigators now know it had been circulating since February—giving it months of undetected spread before the alarm was raised.

The geography and conditions of the outbreak amplify the crisis. Eastern Congo, where cases are concentrated across five provinces, is remote and fractured by ongoing conflict. Health infrastructure is sparse and poorly equipped. Many communities sit beyond the reach of health workers, separated by poor roads and limited resources. Some health workers have stopped showing up, striking over unpaid wages. Misinformation about the virus spreads through communities where suspicion of outsiders runs deep, keeping sick people away from clinics. The virus, meanwhile, spreads through bodily fluids—blood, vomit, semen—and through contaminated materials like bedding and clothing. It is severe and often fatal.

Tedros Adhanom Ghebreyesus, the WHO director-general, described the dynamic plainly: the outbreak had a head start, and responders are playing catch-up. A WHO official projected that under a moderate scenario, the outbreak would peak in six months. But that same official acknowledged a darker possibility: the outbreak could persist for nine to twelve months, continuing to spread and kill.

The speed of this outbreak is historically unprecedented. The 2014-2016 West African epidemic took roughly eight months to reach 1,000 deaths. This outbreak has already surpassed 2,000 deaths in a fraction of that time. Researchers published findings this week in Nature Medicine showing that the virus jumped from an animal to a human—not a continuation of earlier Bundibugyo outbreaks from 2007 or 2012, but a fresh spillover event. The genetic evidence is clear: this is a new introduction of an old virus into a vulnerable population.

Response efforts are underway, though they began late. Clinical trials of two treatments designed specifically for Bundibugyo Ebola started last month in Ituri Province, the hardest-hit region. Two vaccines developed for this virus strain are now being tested in people for the first time. The WHO is also investigating whether an existing Ebola vaccine, proven effective against other strains, might offer protection—animal studies have shown promise. But these interventions are racing against a virus that has already built momentum. The question now is whether the medical response can catch up before the outbreak reaches the grim milestone it is tracking toward.